Issued Patents All Time
Showing 1–25 of 31 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11890348 | Localized delivery of anti-fugetactic agent for treatment of cancer | — | 2024-02-06 |
| 11718683 | Antigen-binding fusion proteins with modified HSP70 domains | Timothy Brauns, Jeffrey A. Gelfand, Huabiao Chen, Stephen J. McCormack | 2023-08-08 |
| 11690902 | Coxiella burnetii epitopes for T cell-targeted Q fever vaccines | Ann Sluder, Timothy Brauns, Anne De Groot, Leonard Jeffrey Moise, Anja Garritsen +1 more | 2023-07-04 |
| 11547694 | CXCR4/CXCR7 blockade and treatment of human papilloma virus-associated disease | Jeffrey A. Gelfand, Sara Pai | 2023-01-10 |
| 11453706 | HSP fusion protein with anti-chemorepellant agent for treatment of infectious disease | Jeffrey A. Gelfand | 2022-09-27 |
| 11419894 | Modified natural killer cells for the treatment of cancer | Patrick Reeves | 2022-08-23 |
| 11364264 | Ex vivo antigen-presenting cells or activated CD-positive T cells for treatment of cancer | Jeffrey A. Gelfand | 2022-06-21 |
| 11325951 | HSP fusion protein with anti-chemorepellant agent for treatment of cancer | Jeffrey A. Gelfand | 2022-05-10 |
| 11305017 | Anti-fugetactic agent and anti-cancer agent combination therapy and compositions for the treatment of cancer | Patrick Reeves | 2022-04-19 |
| 11029313 | Method of treating cervical neoplasia in patients infected with human papilloma virus | Hajah Siti Fatimah Jaafar, Dulcie V. Coleman, Pierre LeBlanc | 2021-06-08 |
| 10800837 | Immunotherapies employing self-assembling vaccines | Jeffrey A. Gelfand, Pierre LeBlanc, Svetlana E. Korochkina | 2020-10-13 |
| 10580262 | Eluting matrix and uses thereof | Tao Chen | 2020-03-03 |
| 10406217 | Antifugetactic agents for the treatment of cancers | John T. Potts, Jr., Fabrizio Vianello, Natalia Papeta | 2019-09-10 |
| 9885720 | Methods for detecting and treating cancer | Hajah Siti Fatimah Jaafar, Dulcie V. Coleman, Pierre LeBlanc | 2018-02-06 |
| 9849094 | Eluting matrix and uses thereof | Tao Chen | 2017-12-26 |
| 9849159 | Eluting matrix and uses thereof | Tao Chen | 2017-12-26 |
| 9789171 | Anti-fugetactic agents for the treatment of ovarian cancer | John T. Potts, Jr., Fabrizio Vianello, Natalia Papeta | 2017-10-17 |
| 9775816 | Eluting matrix and uses thereof | Tao Chen | 2017-10-03 |
| 9527906 | Immunotherapies employing self-assembling vaccines | Jeffrey A. Gelfand, Pierre LeBlanc, Svetlana E. Korochkina | 2016-12-27 |
| 9229004 | Methods for detecting and treating cancer | Hajah Siti Fatimah Jaafar, Dulcie V. Coleman, Pierre LeBlanc | 2016-01-05 |
| 9220813 | Cell therapy for limiting overzealous inflammatory reactions in tissue healing | Nicolas Chronos | 2015-12-29 |
| 8603463 | Recovery of tissue function following administration of B cells to injured tissue | Traci T. Goodchild, Mark Ungs, Nicolas Chronos, Nadine Weich | 2013-12-10 |
| 7951364 | CaR receptor as a mediator of migratory cell chemotaxis and/or chemokinesis | Edward M. Brown, David T. Scadden, Ivona T. Olszak | 2011-05-31 |
| 7775469 | Purposeful movement of human migratory cells away from an agent source | Andrew Luster, David T. Scadden | 2010-08-17 |
| 7745578 | Fugetactic proteins, compositions and methods of use | Dahlia Doughty | 2010-06-29 |